Table 2.
Patient ophthalmologic parameters grouped by stage of diabetic retinopathy
| Stage of DR (number of eyes) | Mild DR (29) | Moderate DR (15) | Severe DR (8) | Proliferative DR (31) | p Value |
|---|---|---|---|---|---|
| Visual acuity (LogMAR; mean ± SD) | 0.23 ± 0.24 | 0.2 ±0.22 | 0.19 ±0.2 | 0.2 ±0.25 | 0.88 |
| Central subfield thickness at first visit, μm (mean ±SD) | 366.3 ± 87.8 | 401.0 ±120.0 | 428.4 ±103.8 | 376.5 ±123.7 | 0.96 |
| Central subfield thickness at time of enrollment, μm (mean ±SD) | 336.6 ±91.31 | 331.8 ±38.6 | 336.5 ±58.9 | 311.9 ±68.8 | 0.57 |
| Number of IVIs (in the last year), mean ± SD | 5.7 ±3.7 | 7.9 ±2.3 | 5.4 ±2.1 | 4.2 ±3.5 | 0.003 |
| Anti-VEGF IVI, n (%) | 25 (86.2) | 15 (100) | 6 (75) | 27 (87.1) | 0.341 |
| Steroid IVI, n (%) | 4 (13.8) | 0 (0) | 2 (25) | 4 (12.9) | 0.121 |
DR diabetic retinopathy, LogMAR logarithm of the minimal angle of resolution, SD standard deviation, IVI intravitreal injection, anti-VEGF anti-vascular endothelial growth factor antibody